Cold Pain Plaster
Natural health product licensed in Canada
- Other names
- MapleLife Cold Pain Plaster, Nutralab Canada Cold Pain Plaster
- Licence holder
- Nutralab Canada Corp.
- NPN or DIN-HM
- 80059603
- Status
- Active licence
- Licence date
- 2 April 2015
- Revision date
- 14 June 2018
- Form
- Plâtre
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Aconitum carmichaelii Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 45 milligramme | 11.25 milligramme |
| Boswellia sacra Source : Gum oleoresin | 18.75 milligramme |
| l-Menthol Source : l-Menthol | 2 % |
| Angelica dahurica Source : Racine Extraction ratio : 2:1 Dry plant equivalent : 22.5 milligramme | 11.25 milligramme |
| Commiphora myrrha Source : Stem resin Extraction ratio : 4:1 Dry plant equivalent : 75 milligramme | 18.75 milligramme |
Non-medicinal ingredients
(p)-hydroxybenzoate de propyle, Extrait de fruit de Prunus Armeniaca (Abricotier), Heizhima, Extrait de racine d'Angelica Polymorpha Sinensis, (p)-hydroxybenzoate de méthyle, Résines de pétrole
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 13 years | 1 pansement adhésif | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If symptoms persist and/or worsen after 7 days or re-occur within a few days, discontinue use and consult a health care practitioner. If you experience pain, swelling or blistering, stop use and get medical help right away.
- Effets indésirables connus
Rashes and/or burning discomfort have been known to occur; in which case, discontinue use. Hypersensitivity has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80059603
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging